POSCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

POSITRON CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$1.70+0.15 (+9.68%)

Close on Oct 19, 2026

Market cap: $55.84M
P/E (TTM): –
Dividend yield: –

POSITRON CORP income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Revenue	0.46	0.59	1.47	1.63	2.80	6.66	4.62
Cost of Revenue	2.58	0.93	1.36	1.21	1.97	6.39	4.56
Gross Profit	-2.11	-0.34	0.10	0.42	0.83	0.28	0.06
Research & Development	–	–	0.47	0.56	0.94	1.32	1.28
Selling, General & Admin	–	–	2.38	3.20	4.61	3.35	13
Selling & Marketing	–	–	0.19	0.42	0.29	1.04	1.10
General & Administrative	8.38	1.86	2.19	2.78	4.33	2.32	12
Advertising Expenses	0.24	0.13	–	–	–	–	–
Operating Expenses	–	–	2.85	3.76	5.55	4.67	15
Operating Income	-10	-2.21	-2.74	-3.34	-4.72	-4.39	-14
Interest Expense	0.13	0.14	1.82	2.14	1.75	1.19	0.04
Other Non-Operating Income	–	–	0.16	-3.77	-3.23	-1.73	3.52
Asset Impairment Charges	–	–	–	0.35	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	0	-0.02	0	–
Pretax Income	–	–	-2.58	-7.10	-7.96	-6.12	-11
Income Tax Expense	–	–	0	0	0	0	–
Net Income	-11	-2.38	-2.58	-7.10	-7.96	-6.12	-11
EPS (Basic)(per share)	-0.34	-0.09	0.00	0.00	-4,000.41	-4,000.41	-8,000.82
EPS (Diluted)(per share)	-0.34	-0.09	0.00	0.00	-4,000.41	-4,000.41	-8,000.82
Shares Outstanding (Basic, Weighted)(shares)	31	26	0.01	0.00	0.00	0.00	–
Shares Outstanding (Diluted, Weighted)(shares)	31	26	0.01	0.00	0.00	0.00	–
EBITDA	–	–	-2.59	-3.18	-4.50	-4.32	-14

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: -458.2%
Operating margin: -2275.1%
Net margin: -2297.8%
Return on equity, FY2025: -2694.3%

Financial strength

Current ratio: 0.49
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 15.9%

Valuation

P/E ratio: –
Price to sales: 121.02
Price to book: –
Dividend yield: –